Table 1 |
|
Advantages of universal leukocyte reduction |
|
Reduction in transfusion reactions; HLA alloimmunization; and CMV, HTLV-I, EBV, HHV-6 and HHV-8 transmission |
|
Improved RBC quality |
|
Reduction in parasite and prion transmission, bacterial sepsis, and acute lung injury |
|
May decrease postoperative abdominal infection, morbidity and mortality in cardiac surgery, and multisystem organ failure |
|
Avoids errors, decreases workload, and simplifies blood bank inventory |
|
No need for a filter, saving time and education |
|
|
|
Reproduced with permission from [1]. © 2001, American Society of Clinical Pathologists. CMV, cytomegalovirus; EBV, Epstein–Barr virus; HHV, human herpesvirus; HTLV, human T-cell leukemia virus; RBC, red blood cell. |
|
Shapiro Critical Care 2004 8(Suppl 2):S27 doi:10.1186/cc2453 |